Evidence map›Paper›PMID 31938104›Full record

ArticleInternational journal of clinical and experimental pathology2018

Rab5a promotes the migration and invasion of hepatocellular carcinoma by up-regulating Cdc42.

Xiao Yang, Zhengshu Liu, Yongguo Li, Ke Chen, Hong Peng, Liying Zhu, Huihao Zhou, Ailong Huang, Hua Tang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RHO GTPase family in hepatocellular carcinoma.Experimental hematology & oncology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiao YangKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Zhengshu LiuDepartment of Physical Examination, The First Affiliated Hospital of Chongqing Medical University Chongqing, China.
Yongguo LiDepartment of Forensic Medicine, Chongqing Medical University Chongqing, China.
Ke ChenKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Hong PengKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Liying ZhuKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Huihao ZhouKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Ailong HuangKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Hua TangKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University Chongqing, China.
Chongqing Medical University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are many factors participating in the process of human hepatocellular carcinoma (HCC) occurrence and development. In this study, romoted cell invasion and migration

Indexed as

Cdc42HCCinvasionmigrationRab5a

Identifiers

PMID31938104
PMCPMC6957975
OpenAlexW3020086460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.